GSK completes transaction with Pfizer
GSK has a controlling equity interest of 68% and Pfizer has an equity interest of 32% in the venture.
Read More
Tag: transaction
AbbVie to buy Allergan in $63b mega-merger
The deal is the second huge merger this year, after January’s Bristol-Myers Squibb & Celgene deal.
Read More
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
